Quick Answer
LIFECORE BIOMEDICAL, INC. \DE\ reported Net Income of -$38.72 million for fiscal year 2025.
LIFECORE BIOMEDICAL, INC. \DE\ Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$38.72M | -422.3% |
| 2024 | $12.01M | +112.1% |
| 2023 | -$99.56M | +14.7% |
| 2022 | -$116.72M | -261.4% |
| 2021 | -$32.29M | +15.4% |
| 2020 | -$38.19M | -9392.2% |
| 2019 | $411.0K | -98.3% |
| 2018 | $24.83M | +134.5% |
| 2017 | $10.59M | +191.0% |
| 2016 | -$11.64M | -185.9% |
| 2015 | $13.54M | -40.0% |
| 2013 | $22.59M | +77.9% |
| 2012 | $12.70M | +223.9% |
| 2011 | $3.92M | -1.6% |
| 2010 | $3.98M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$9.99M | — | +32.4% |
| February 28, 2025 | -$14.77M | -194.5% | -124.8% |
| November 30, 2024 | -$6.57M | -146.2% | +59.5% |
| August 31, 2024 | -$16.23M | -50.9% | -203.8% |
| February 29, 2024 | $15.63M | +142.8% | +9.9% |
| November 30, 2023 | $14.22M | +211.0% | +232.2% |
| August 31, 2023 | -$10.75M | +1.9% | +70.5% |
| February 28, 2023 | -$36.51M | -179.0% | -185.1% |
- LIFECORE BIOMEDICAL, INC. \DE\ showed a decrease of -422.3% in Net Income compared to the prior fiscal year.
- Over the 2010–2025 period, LIFECORE BIOMEDICAL, INC. \DE\’s net income has declined by 1071.8% (from $3.98 million to -$38.72 million).
- The most recent figure is from LIFECORE BIOMEDICAL, INC. \DE\’s fiscal year 2025 report (Form 10-K), filed with the SEC on August 7, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: